Educational Intervention for Cancer Survivors' Breast Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help women who survived childhood cancer understand and improve their breast and heart health. Over the course of a year, participants will learn about potential health risks and ways to stay healthy through surveys and questionnaires. The trial specifically targets women who received chest radiation as part of their childhood cancer treatment and have not had a mammogram or breast imaging in the last two years. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to significant advancements in healthcare.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that educational tools like videos and digital apps are generally safe and easy to use. For example, one study found that a breast cancer educational video increased knowledge in 62% of viewers and reduced distress in 30% of them. Another review found that digital health tools improved health outcomes for breast cancer survivors without causing harm.
These results suggest that the educational methods tested in the EMPOWER study are very safe for participants. Since the trial is in a late stage, it has undergone extensive testing, indicating that earlier studies have shown the methods to be safe. Overall, participants can feel confident about the safety of joining this study.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on improving breast cancer screening among cancer survivors through educational interventions. Unlike standard breast cancer screening options, which typically rely on traditional imaging methods like mammograms, this trial emphasizes the importance of education and awareness. By using questionnaires and surveys, the trial aims to empower women with knowledge about their health and encourage proactive screening behaviors. This approach is particularly important for those who have undergone chest radiation and might be at higher risk, offering a personalized method to increase screening rates and potentially improve early detection outcomes.
What evidence suggests that these educational interventions are effective for improving breast cancer screening in cancer survivors?
This trial will compare an educational intervention with an attention control group to assess its impact on breast cancer screening among cancer survivors. Research has shown that educational programs effectively increase knowledge and change attitudes about breast cancer screening. Studies have found that these programs encourage more women to participate in screenings. Specifically, clear information and guidance can greatly influence women's views and participation in these screenings. While some educational efforts might not lead to immediate action, they can prepare women to make better health decisions in the future. Overall, educating women about breast health is a promising approach.678910
Who Is on the Research Team?
Chaya Moskowitz, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for adult women aged 25-49 who survived childhood cancer, were treated with chest radiation before turning 21, and haven't had breast imaging in the last two years. They must have been part of the CCSS cohort and not diagnosed with breast cancer or participated in Project VISION.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive mailed tailored print materials followed by a telephone-delivered Brief Motivational Interview
Follow-up
Participants are monitored for completion of mammogram screening and other health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Questionnaire
- Survey
Trial Overview
The study compares two methods to educate these women about their health risks and promote wellness, focusing on breast and heart health over a twelve-month period. It's designed specifically for those who received significant chest radiation as children.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The EMPOWER intervention trial is a 12-month study of 360 women from the Childhood Cancer Survivor Study who have previously been treated with chest radiation, are 25 to 49 years of age at the time of enrollment, are 8 years or more since their chest radiation, and have not had a mammogram or other breast imaging study in the preceding two years. Following a baseline questionnaire, participants will be randomized to the attention control group (N=120) or the intervention group (N=240).
The EMPOWER intervention trial is a 12-month study of 360 women from the Childhood Cancer Survivor Study who have previously been treated with chest radiation, are 25 to 49 years of age at the time of enrollment, are 8 years or more since their chest radiation, and have not had a mammogram or other breast imaging study in the preceding two years. Following a baseline questionnaire, participants will be randomized to the attention control group (N=120) or the intervention group (N=240).
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
University of Chicago
Collaborator
University of Colorado, Denver
Collaborator
Dana-Farber Cancer Institute
Collaborator
St. Jude Children's Research Hospital
Collaborator
Published Research Related to This Trial
Citations
The Effectiveness of Educational Interventions on Breast ...
This review paper aimed to systematically evaluate the effectiveness of various educational interventions in improving BCS uptake, knowledge, and beliefs among ...
Impact of an educational intervention on provider knowledge ...
An educational intervention detailing recommendations and counseling methods affected the knowledge and attitudes about breast cancer screening.
Effectiveness of a telehealth patient education intervention ...
These findings in conjunction with the findings of the present study suggest that patient education interventions are highly effective at improving cancer ...
Effectiveness of Breast Density Educational Interventions ...
Conclusion: Informational interventions targeting BD education alone are unlikely to significantly improve adherence to subsequent mammography among Latinas ...
Revolutionizing Breast Cancer Screening: Integrating ...
By integrating AI with clinical breast examination (CBE) and ultrasound imaging, these tools can improve the accuracy and efficiency of early breast cancer ...
Evidence-based digital health interventions for breast ...
We conducted an umbrella review to summarize the evidence on digital health interventions aimed at improving health-related outcomes for BCS.
Standard Verbal Counseling With or Without a Pictorial ...
This clinical trial studies the effect of standard verbal counseling with or without a pictorial educational tool for the reduction of ...
Educational Intervention for Breast Cancer Risk
A breast cancer educational video (BCV) significantly improved knowledge about breast cancer in 62% of patients and reduced distress in 30% of those who ...
The Effectiveness of Educational Interventions on Breast ...
This review paper aimed to systematically evaluate the effectiveness of various educational interventions in improving BCS uptake, knowledge, and beliefs among ...
Screening for Breast Cancer: Evidence Report and ...
Trials have established that screening mammography can reduce mortality risk, but optimal screening ages, intervals, and modalities for population screening ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.